Nanomedicines for the Delivery of Antimicrobial Peptides (AMPs).
antimicrobial peptides
antimicrobial resistance
bacterial and virus infections
coronavirus
nanomaterials
nanomedicine
Journal
Nanomaterials (Basel, Switzerland)
ISSN: 2079-4991
Titre abrégé: Nanomaterials (Basel)
Pays: Switzerland
ID NLM: 101610216
Informations de publication
Date de publication:
20 Mar 2020
20 Mar 2020
Historique:
received:
09
03
2020
revised:
12
03
2020
accepted:
13
03
2020
entrez:
5
4
2020
pubmed:
5
4
2020
medline:
5
4
2020
Statut:
epublish
Résumé
Microbial infections are still among the major public health concerns since several yeasts and fungi, and other pathogenic microorganisms, are responsible for continuous growth of infections and drug resistance against bacteria. Antimicrobial resistance rate is fostering the need to develop new strategies against drug-resistant superbugs. Antimicrobial peptides (AMPs) are small peptide-based molecules of 5-100 amino acids in length, with potent and broad-spectrum antimicrobial properties. They are part of the innate immune system, which can represent a minimal risk of resistance development. These characteristics contribute to the description of these molecules as promising new molecules in the development of new antimicrobial drugs. However, efforts in developing new medicines have not resulted in any decrease of drug resistance yet. Thus, a technological approach on improving existing drugs is gaining special interest. Nanomedicine provides easy access to innovative carriers, which ultimately enable the design and development of targeted delivery systems of the most efficient drugs with increased efficacy and reduced toxicity. Based on performance, successful experiments, and considerable market prospects, nanotechnology will undoubtedly lead a breakthrough in biomedical field also for infectious diseases, as there are several nanotechnological approaches that exhibit important roles in restoring antibiotic activity against resistant bacteria.
Identifiants
pubmed: 32244858
pii: nano10030560
doi: 10.3390/nano10030560
pmc: PMC7153398
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Pharmaceutics. 2020 Feb 16;12(2):
pubmed: 32079103
Eur J Pharm Biopharm. 2014 May;87(1):1-18
pubmed: 24530885
Biomaterials. 2001 Nov;22(21):2857-65
pubmed: 11561891
Int J Nanomedicine. 2012;7:2109-13
pubmed: 22619547
J Mater Chem B. 2014 Mar 28;2(12):1706-1716
pubmed: 32261400
Eur J Pharm Biopharm. 2016 Nov;108:310-316
pubmed: 27080206
Pharmaceutics. 2019 Oct 14;11(10):
pubmed: 31615120
Nature. 1996 Sep 19;383(6597):219-20
pubmed: 8805692
Int J Pharm. 2015 Nov 10;495(1):560-571
pubmed: 26363112
Small. 2010 Feb 22;6(4):517-22
pubmed: 20029850
Methods Enzymol. 2009;464:105-29
pubmed: 19903552
Nat Mater. 2009 Dec;8(12):935-9
pubmed: 19881498
J Mater Sci Mater Med. 2009 Dec;20 Suppl 1:S235-41
pubmed: 18716714
Theranostics. 2020 Jan 1;10(2):671-686
pubmed: 31903144
Science. 2006 May 19;312(5776):1027-30
pubmed: 16709779
Mol Pharm. 2016 Jul 5;13(7):2318-31
pubmed: 27182713
Biomaterials. 1998 Jun;19(11-12):1009-17
pubmed: 9692799
Food Chem. 2015 Dec 1;188:161-9
pubmed: 26041178
Adv Drug Deliv Rev. 2013 Nov;65(13-14):1803-15
pubmed: 23892192
Colloids Surf B Biointerfaces. 2016 May 1;141:450-457
pubmed: 26895507
Front Microbiol. 2018 May 08;9:855
pubmed: 29867793
Nanomaterials (Basel). 2020 Feb 09;10(2):
pubmed: 32050443
Nano Today. 2014 Aug 1;9(4):478-498
pubmed: 25267927
Int J Pharm. 2017 Jun 30;526(1-2):244-253
pubmed: 28461263
J Antimicrob Chemother. 1992 Aug;30(2):173-9
pubmed: 1399927
Eur J Pharm Sci. 2015 May 25;72:27-33
pubmed: 25724130
ACS Omega. 2017 Feb 28;2(2):554-562
pubmed: 28261690
Nat Rev Microbiol. 2012 Mar 16;10(4):266-78
pubmed: 22421879
J Virol. 2007 Jun;81(11):5637-48
pubmed: 17344287
Langmuir. 2006 Nov 21;22(24):10125-9
pubmed: 17107009
Nature. 1976 Oct 28;263(5580):797-800
pubmed: 995197
Eur J Pharm Biopharm. 2008 Mar;68(3):535-44
pubmed: 17804210
Biosens Bioelectron. 2015 Dec 15;74:546-53
pubmed: 26188677
Int J Biol Macromol. 2015 Aug;79:95-102
pubmed: 25907011
Curr Pharm Des. 2015;21(28):4095-105
pubmed: 26420233
Sci Rep. 2016 Aug 04;6:31030
pubmed: 27491007
Trends Biotechnol. 2012 Oct;30(10):499-511
pubmed: 22884769
Eur J Pharm Biopharm. 2015 May;92:112-9
pubmed: 25769679
J Am Chem Soc. 2016 May 4;138(17):5507-10
pubmed: 27103596
N Engl J Med. 2013 Jan 24;368(4):299-302
pubmed: 23343059
Nanomaterials (Basel). 2020 Mar 04;10(3):
pubmed: 32143286
Adv Drug Deliv Rev. 2007 Jul 10;59(6):478-90
pubmed: 17543416
Curr Med Chem. 2010;17(6):585-94
pubmed: 20015030
J Control Release. 2014 Aug 10;187:101-17
pubmed: 24878179
Int J Pharm. 2006 Jan 3;307(1):93-102
pubmed: 16303268
J Appl Toxicol. 2014 Apr;34(4):395-403
pubmed: 24243595
Peptides. 2015 Oct;72:88-94
pubmed: 26048089
Appl Microbiol Biotechnol. 2015 Mar;99(5):2023-40
pubmed: 25586583
Int J Pharm. 2006 Jul 6;317(1):82-9
pubmed: 16580159
Pharmaceutics. 2019 Sep 02;11(9):
pubmed: 31480680
J Nanobiotechnology. 2016 Jul 13;14(1):58
pubmed: 27412259
Biomaterials. 2016 Apr;85:99-110
pubmed: 26866877
Colloids Surf B Biointerfaces. 2015 Nov 1;135:717-25
pubmed: 26340361
Acta Biomater. 2014 May;10(5):2105-11
pubmed: 24434534
Adv Drug Deliv Rev. 2014 Nov 30;78:14-27
pubmed: 25450262
Adv Drug Deliv Rev. 2003 Apr 25;55(4):519-48
pubmed: 12706049
Pharmaceutics. 2020 Feb 11;12(2):
pubmed: 32053962
J Mater Chem B. 2016 Feb 7;4(5):824-833
pubmed: 32263154
J Control Release. 2001 Jan 29;70(1-2):1-20
pubmed: 11166403
J Control Release. 2011 Dec 10;156(2):128-45
pubmed: 21763369
Chem Soc Rev. 2015 Apr 7;44(7):1820-35
pubmed: 25649260
Eur J Pharm Biopharm. 2015 May;92:65-73
pubmed: 25701808
Nat Mater. 2008 Mar;7(3):236-41
pubmed: 18204453
Antibiotics (Basel). 2020 Jan 16;9(1):
pubmed: 31963311
Cancer Drug Deliv. 1984;1(2):119-23
pubmed: 6544628
Int J Pharm. 2013 Jan 20;440(2):135-40
pubmed: 23078856
Nanoscale. 2015 Feb 28;7(8):3511-9
pubmed: 25628231
Science. 2006 Jan 20;311(5759):374-7
pubmed: 16424339
Biomacromolecules. 2014 Apr 14;15(4):1337-45
pubmed: 24588750
Jundishapur J Microbiol. 2016 Jan 02;9(1):e27997
pubmed: 27099683
Science. 1994 Apr 15;264(5157):388-93
pubmed: 8153626
Eur J Pharm Sci. 2019 Feb 1;128:27-35
pubmed: 30472221
Carbohydr Polym. 2015;127:451-61
pubmed: 25965504
Langmuir. 2013 Apr 16;29(15):4647-51
pubmed: 23544954
Biomaterials. 2007 Feb;28(5):869-76
pubmed: 17055572
J Am Chem Soc. 2002 Apr 10;124(14):3508-9
pubmed: 11929231
Toxicol In Vitro. 2015 Apr;29(3):638-46
pubmed: 25482991
Adv Colloid Interface Sci. 2017 Apr;242:17-34
pubmed: 28159168
Front Microbiol. 2015 Apr 28;6:372
pubmed: 25972852
Curr Pharm Des. 2014;20(5):771-92
pubmed: 23688084
J Oleo Sci. 2018 Aug 1;67(8):1035-1041
pubmed: 30012902
Pharmaceuticals (Basel). 2013 Nov 28;6(12):1543-75
pubmed: 24287494
PLoS Pathog. 2011 Jul;7(7):e1002158
pubmed: 21811410
J Colloid Interface Sci. 2016 Aug 1;475:161-170
pubmed: 27174622
Proc Natl Acad Sci U S A. 2008 Nov 4;105(44):16837-42
pubmed: 18955695
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):547-59
pubmed: 19914315
Expert Opin Drug Deliv. 2008 Sep;5(9):931-49
pubmed: 18754746
Eur J Pharm Biopharm. 2016 Nov;108:235-252
pubmed: 27519829
Microbiol Mol Biol Rev. 2001 Jun;65(2):232-60 ; second page, table of contents
pubmed: 11381101
Nanoscale. 2015 Dec 7;7(45):19160-9
pubmed: 26524425
J Appl Microbiol. 2016 Mar;120(3):527-42
pubmed: 26599354
Biomolecules. 2018 Jan 19;8(1):
pubmed: 29351202
Nanomaterials (Basel). 2020 Feb 23;10(2):
pubmed: 32102229
Pharm Res. 2015 Aug;32(8):2727-35
pubmed: 25813840
Environ Sci Technol. 2011 Jul 1;45(13):5564-71
pubmed: 21630686
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):560-75
pubmed: 19914313
J Hosp Infect. 2014 Dec;88(4):183-90
pubmed: 25447199
Lab Chip. 2012 Mar 21;12(6):1052-9
pubmed: 22193301
Mater Sci Eng C Mater Biol Appl. 2016 Mar;60:246-254
pubmed: 26706528
Macromol Rapid Commun. 2018 Dec;39(24):e1800622
pubmed: 30408252
Pharm Dev Technol. 2018 Mar;23(3):265-274
pubmed: 28128676
Int J Biol Macromol. 2014 Jun;67:124-31
pubmed: 24661890
Int J Nanomedicine. 2015 Mar 18;10:1953-60
pubmed: 25834427
Colloids Surf B Biointerfaces. 2015 Jan 1;125:190-6
pubmed: 25497291